| 60498 |
ONCOLOGY REPORTS |
Association between metalloproteinases 2 and 9 activity and ERK1/2 phosphorylation status in head and neck cancers: An ex vivo study |
2010-09-02 |
10.3892/or.2010.1073 |
Maggioni |
| 60497 |
ONCOLOGY REPORTS |
Acquired resistance to miriplatin in rat hepatoma AH109A/MP10 is associated with increased Bcl-2 expression, leading to defects in inducing apoptosis |
2010-09-02 |
10.3892/or.2010.1011 |
Hanada |
| 60496 |
ONCOLOGY REPORTS |
High-level transgene expression mediated by the piggyBac transposon enhances transgenic therapeutic effects in cervical cancer xenografts |
2010-09-02 |
10.3892/or_00000935 |
Xu |
| 60495 |
ONCOLOGY REPORTS |
Pathotropic targeting advances clinical oncology: Tumor-targeted localization of therapeutic gene delivery |
2010-09-02 |
10.3892/or.2010.829 |
Gordon |
| 60494 |
ONCOLOGY REPORTS |
p53 mutation, but not in vitro predictor genes of therapeutic efficacy of cisplatin, is clinically relevant in comparing partial and complete responder cases of maxillary squamous cell carcinoma |
2010-09-02 |
10.3892/or.2010.851 |
Esumi |
| 60493 |
ONCOLOGY REPORTS |
Genetic profiles distinguish different types of hereditary ovarian cancer |
2010-09-02 |
10.3892/or.2010.885 |
Domanska |
| 60492 |
ONCOLOGY REPORTS |
Nutrition in oncology: the case of micronutrients (Review) |
2010-09-02 |
10.3892/or.2010.815 |
Ströhle |
| 60491 |
ONCOLOGY REPORTS |
VEGFR and EGFR inhibition increases epithelial cellular characteristics and chemotherapy sensitivity in mesenchymal bladder cancer cells |
2010-09-02 |
10.3892/or.2010.1019 |
Yang |
| 60490 |
ONCOLOGY REPORTS |
RhoA protein is generally distributed in the nuclei of cancer cells |
2010-09-02 |
10.3892/or.2010.1005 |
Chen |
| 60489 |
ONCOLOGY REPORTS |
Up-regulation of NKG2F receptor, a functionally unknown killer receptor, of human natural killer cells by interleukin-2 and interleukin-15 |
2010-09-02 |
10.3892/or.2010.1043 |
Sun |
